Iranian Journal of Parasitology 2017. 12(3):446-452.

Antiparasitic Activity of Mirazid, Myrrh Total Oil and Nitazoxanide Compared to Praziquantel on Schistosoma Mansoni: Scanning Electron Microscopic Study
Mona EL-SAYAD, Sahar ABU HELW, Hend EL-TAWEEL, Mohammad AZIZ

Abstract


Background: The development of new antischistosomal drug remains a pressing need and a vital challenge in front of many researchers through screening the natural or chemical substances for their potential activity as antischistosomal agents.

Methods: Five groups of Schistosoma mansoni-infected mice (n=10) were enrolled in this study, the G1 was infected non-treated control group. G2 was infected treated with praziquantel 500 mg/kg for 2 consecutive days. G3 was given mirazid 500 mg/kg for 5 days. G4 was given Myrrh total oil 18 mg/kg for 3 days and G5 given nitazoxanide 100 mg/kg for 7 days. Mice perfusion was performed for worm ultrastructural morphology by scanning electron microscopy at 2 WPT.

Results: Praziquantel was superior to any other tested substances as it caused extensive tegumental damages in male worms in the form of rupture of the tubercles and loss of spines followed by mirazid that resulted only in superficial tegumental damage with shrinkage of the outer surface of male tubercles with marked loss of spines. Nitazoxanide resulted in minor tegumental alterations of male worms while Myrrh total oil caused negligible effects on the teguments of perfused worms.

Conclusion: PZQ showed more superior antiparasitic effects than all tested substances on S. mansoni worms. Mirazid was more effective than myrrh total oil and nitazoxanide.

Keywords


Mirazid, Mice, Myrrh, Nitazoxanide, Praziquantel, Scanning electron micros-copy, Schistosoma mansoni

Full Text:

PDF

References


Loukas A, Tran M, Pearson MS. Schistosome membrane proteins as vaccines. Int J Parasitol. 2007;37(3-4):257-63.

Van Hellemond JJ, Retra K, Brouwers JF et al. Functions of the tegument of schistosomes: Clues from the proteome and lipidome. Int J Parasitol. 2006;36(6):691-9.

Zhang SM, Coultas KA. Identification of plumbagin and sanguinarine as effective chemotherapeutic agents for treatment of schistosomiasis. Int J Parasitol Drugs Drug Resist. 2013;3:28-34.

Shaohong L, Kumagai T, Qinghua A et al. Evaluation of the anthelmintic effects of artesunate against experimental Schistosoma mansoni infection in mice using different treatment protocols. Parasitol Int. 2006;55(1):63-8.

Voge M, Bueding E. Schistosoma mansoni: Tegumental surface alterations induced by subcurative doses of the schistosomicide Amoscanate. Exp Parasitol. 1980;50(2):251-9.

Hassan M, El-Motaiem M, Afify H et al. In vitro effect of Mirazid on Schistosoma mansoni worms. J Egypt Soc Parasitol. 2003;33(3):999-1008.

Popiel I, Irving DL, Basch PF. Wound healing in the trematode Schistosoma. Tissue Cell. 1985;17(1):69-77.

Harnett W, Kusel JR. Increased exposure of parasite antigens at the surface of adult male Schistosoma mansoni exposed to Praziquantel in vitro. Parasitology. 1986;93( Pt 2):401-5.

Shaw MK, Erasmus DA. Schistosoma mansoni: Structural damage and tegumental repair after in vivo treatment with praziquantel. Parasitology. 1987;94 ( Pt 2):243-54.

Tran MH, Pearson MS, Bethony JM et al. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med. 2006;12(7):835-40.

Alsaqabi SM, Lotfy WM. Praziquantel: A Review. J Veterinar Sci Technol. 2014;5(5): 200.

Inobaya MT, Olveda RM, Chau TN et al. Prevention and control of schistosomiasis: a current perspective. Res Rep Trop Med. 2014;2014(5):65-75.

Glaser J, Schurigt U, Suzuki BM et al. Antischistosomal activity of Cinnamic acid esters: eugenyl and thymyl cinnamate induce cytoplasmic vacuoles and death in schistosomula of Schistosoma mansoni. Molecules. 2015; 20(6):10873-83.

Sadhu PS, Kumar SN, Chandrasekharam M et al. Synthesis of new praziquantel analogues: potential candidates for the treatment of schistosomiasis. Bioorg Med Chem Lett. 2012;22(2):1103-6.

de Moraes J. Natural products with antischistosomal activity. Future Med Chem. 2015; 7(6):801-20.

Abdulla MH, Ruelas DS, Wolff B et al. Discovery for Schistosomiasis: Hit and Lead Compounds Identified in a Library of Known Drugs by Medium-Throughput Phenotypic Screening. PLoS Negl Trop Dis. 2009; 3(7):e478.

Gelmedin V, Dissous C, Grevelding CG. Re-positioning protein-kinase inhibitors against schistosomiasis. Future Med Chem. 2015;7(6):737-52.

Abdul-Ghani RA, Loutfy N, Hassan A. Myrrh and trematodoses in Egypt: An overview of safety, efficacy and effectiveness profiles. Parasitol Int. 2009;58(3):210-4.

Massoud AM, Salama O, Bennett JL. The therapeutic efficacy of a new schistosomicidal drug, derived from Myrrh in active intestinal schistosomiasis complicated with hepatosplenomegally. Parasitol Int. 1998;47 (suppl.1): 125.

Yakoot M. A short review of the anthelmintic role of Mirazid. Arq Gastroenterol. 2010; 47(4):393-4.

Osman MM, El-Taweel HA, Shehab AY et al.Ineffectiveness of myrrh-derivative Mirazid against schistosomiasis and fascioliasis in humans. East Mediterr Health J. 2010:16(9):932-6.

Massoud A. Efficacy of myrrh as a new schistosomiasis: An experimental study. Ain Shams Med J. 1999;50: 1287-98.

Massoud AM, Shalaby HA, El Khateeb RM et al. Effects of Mirazid and myrrh volatile oil on adult Fasciola gigantica under laboratory conditions. Asian Pac J Trop Biomed. 2012; 2(11):875-84.

Etman M, Amin M, Nada AH et al. Emulsion and rectal formulations containing myrrh essential oil for better patient compliance. Drug Discov Ther.2011;5(3):150-6.

Fox LM, Saravolatz LD. Nitazoxanide: A New Thiazolide Antiparasitic Agent. Clin Infect Dis. 2005; 40(8):1173-80.

Liang. YS, Bruce JI, Boyd DA.Laboratory cultivation of schistosome vector snails and maintenance of schistosome life cycles. Proc.1st Sino-American Symp. 1987; 1: 34-48.

Smithers SR, Terry RJ. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of adult worms. Parasitology. 1965; 55(4):695-700.

Khalil SS. On the schistosomicidal effect of Triclabendazole an experimental study. J Egypt Soc Parasitol. 2000; 30(3):799-808.

William S, Guirguis F, Nessim NG. Effect of simultaneous and/or consecutive administration of the broad-spectrum anthelmintic flubendazole together with praziquantel in experimental Schistosoma mansoni infection. Arzneimittelforschung.2003; 53(7):532-7.

Massoud AM, El Ebiary FH, Abou-Gamra MM et al. Evaluation of schistosomicidal activity of myrrh extract: parasitological and histological study. J Egypt Soc Parasitol. 2004; 34(3 Suppl):1051-76.

Botros S, William S, Ebeid F et al. Lack of evidence for an antischistosomal activity of myrrh in experimental animals. Am J Trop Med Hyg. 2004; 71(2):206-10.

Khamis M. Formulation and evaluation of various dosage forms of Myrrh. Master Thesis, 2006,Faculty of Pharmacy, Alexandria University, Alexandria; Egypt.

Bricker CS, Depenbusch A, Bennett JL et al. The relationship between tegumental disruption and muscle contraction in Schistosoma mansoni worms exposed to various compounds. J Parasitol. 1983; 69 :61-71.

Becker B, Mehlhorn H, Andrews P et al. Light and electron microscopic studies on the effect of praziquantel on Schistosoma mansoni, Dicrocoelium dendriticum, and Fasciola hepatica (Trematoda) in vitro. Z Parasitenkd. 1980; 63(2):113-28.

Melhorn H, Becker B, Andrews P et al. In vitro experiments on the effect of Praziquantel on Schistosoma mansoni. Arzneimittelforschung 1981; 31:544-54.

Shaw MK. Schistosoma mansoni: stage dependent damage after in vitro treatment with praziquantel. Parasitology 1990;100: 65.

Shalaby IM. Ultrastructural changes on the tegumental surface of Schistosoma mansoni (Egyptian strain) after in vitro treatment with Praziquantel. J Egypt Ger Soc Zool.1994; 14D: 397-411.

Shaw MK, Erasmus DA.Schistosoma mansoni: the effect of a subcurative dose of praziquantel on the ultrastructure of worms in vivo. Z Parasitenkd. 1983; 69(1):73-90.

Awadalla HN, el Azzouni MZ, Khalil AI et al. Scanning electron microscopy of normal and Praziquantel treated S. haematobium worms (Egyptian strain). J Egypt Soc Parasitol. 1991;21(3):715-22.

Mohamed SH, Fawzi SM. Scanning electron microscopy on adults of Schistosoma mansoni treated in vivo with Praziquantel and RO-15(5458).Qatar Univ Sci J.1997; 17(2):349-58.

Sharaf O F.The effect of antischistosome drugs on schistosomes and the immune response of their hosts. MD Thesis, Institute of Biomedical Life Sciences. Division of Infection & Immunity. University of Glasgow. 2004.

Eissa MM, Allam SR, El-Azzouni MZ et al. Comparative efficacy study of Praziquantel and Albendazole treatment in experimental schistosomiasis. Bull Alex Fac Med. 2004; 40(2):147-50.

Ramzy F, Mahmoud S, William S. Further assessment of Mirazid as antischistosomal drug in experimental Schistosomiasis hematobium. Pharm Biol. 2010; 48(7):775-9.

Bakr M, El-Sobky M, Harba N et al. Study of in vivo and in vitro effects of Mirazid on murine Schistosomiasis mansoni. J Schistosomiasis Infect Endem Dis.2009; 31:35-49.

El Ashry ESH, Rashed N, Soliman A S et al. Evaluation of molluscicidal activity of Commiphora molmol on Biomphilaria alexandrina snails. Alex J Pharm Sci. 2003;17(1):63-6.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.